叮当快药流感相关药品销量环比成倍增长
Bei Jing Shang Bao·2025-12-03 07:22

Core Insights - Demand for flu-related medications and testing reagents on the platform has surged significantly recently [1] Group 1: Sales Performance - Sales of the new antiviral drug "Sufuda" increased by 900% month-over-month [1] - Sales of the classic antiviral "Oseltamivir" rose by 700% month-over-month [1] - Sales of the children's medication "Kewai Granules" saw a month-over-month increase of 115% [1] - Sales of the children's formulation "Sufuda Dry Suspension" increased by 76% month-over-month [1] Group 2: Supply Chain Management - The company replenishes stock in regular regions 2-3 times a week [1] - The company can initiate cross-regional real-time allocation to ensure timely access to medications if demand surges in specific areas [1] Group 3: Health Advisory - Online pharmacists from the company advise minimizing prolonged gatherings in crowded, poorly ventilated indoor spaces during winter [1] - Recommendations include wearing masks and practicing hand hygiene when going out [1]

叮当快药流感相关药品销量环比成倍增长 - Reportify